The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis

Biochemical Journal

Volumn 473, Issue 4, 2016, Pages 449-461

  Kawaguchi, Koichiro ^a   Kinameri, Ayumi ^a   Suzuki, Shunsuke ^a   Senga, Shogo ^a   Ke, Youqiang ^b   Fujii, Hiroshi ^a  

^a SHINSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

DNA methylation; Epigenetics; FABP5; Fatty acid binding proteins (FABPs); Metastasis; Prostate cancer

Indexed keywords

BISULFITE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; GENOMIC DNA; MYC PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; FABP5 PROTEIN, HUMAN;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CHROMATIN IMMUNOPRECIPITATION; COMBINED BISULFITE RESTRICTION ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; E BOX ELEMENT; EPIGENETICS; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; INTRON; LUCIFERASE ASSAY; MALE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROSTATE CARCINOGENESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TATA BOX; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; SP1 TRANSCRIPTION FACTOR;

EID: 84958555054     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20150926     Document Type: Article

References (72)

1. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R.C., Ghafoor, A., Feuer, E.J. and Thun, M.J. (2005) Cancer statistics, 2005. CA Cancer J. Clin. 55, 10-30
2. Landis, S.H., Murray, T., Bolden, S. and Wingo, P.A. (1999) Cancer statistics, 1999. CA Cancer J. Clin. 49, 8-31
3. Foster, C.S., Cornford, P., Forsyth, L., Djamgoz, M.B. and Ke, Y. (1999) The cellular and molecular basis of prostate cancer. BJU Int. 83, 171-194
4. Liang, P. and Pardee, A.B. (2003) Analysing differential gene expression in cancer. Nat. Rev. Cancer 3, 869-876
5. Morgan, E.A., Forootan, S.S., Adamson, J., Foster, C.S., Fujii, H., Igarashi, M., Beesley, C., Smith, P.H. and Ke, Y. (2008) Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppression. Int. J. Oncol. 32, 767-775
6. Adamson, J., Morgan, E.A., Beesley, C., Mei, Y., Foster, C.S., Fujii, H., Rudland, P.S., Smith, P.H. and Ke, Y. (2003) High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene 22, 2739-2749
7. Jing, C., Beesley, C., Foster, C.S., Chen, H., Rudland, P.S., West, D.C., Fujii, H., Smith, P.H. and Ke, Y. (2001) Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res. 61, 4357-4364
8. Jing, C., Beesley, C., Foster, C.S., Rudland, P.S., Fujii, H., Ono, T., Chen, H., Smith, P.H. and Ke, Y. (2000) Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer. Cancer Res. 60, 2390-2398
9. Chen, R., Feng, C. and Xu, Y. (2011) Cyclin-dependent kinase-associated protein Cks2 is associated with bladder cancer progression. J. Int. Med. Res. 39, 533-540
10. Sinha, P., Hütter, G., Köttgen, E., Dietel, M., Schadendorf, D. and Lage, H. (1999) Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-σ (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis 20, 2952-2960
11. Fujii, K., Kondo, T., Yokoo, H., Yamada, T., Iwatsuki, K. and Hirohashi, S. (2005) Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 5, 1411-1422
12. Fang, L.Y., Wong, T.Y., Chiang, W.F. and Chen, Y.L. (2010) Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. J. Oral Pathol. Med. 39, 342-348
13. Jeong, C.Y., Hah, Y.S., Cho, B.I., Lee, S.M., Joo, Y.T., Jung, E.J., Jeong, S.H., Lee, Y.J., Choi, S.K., Ha, W.S. et al. (2012) Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma. Oncol. Rep. 28, 1283-1292
14. Liu, R.Z., Graham, K., Glubrecht, D.D., Germain, D.R., Mackey, J.R. and Godbout, R. (2011) Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy. Am. J. Pathol. 178, 997-1008
15. Watanabe, R., Fujii, H., Odani, S., Sakakibara, J., Yamamoto, A., Ito, M. and Ono, T. (1994) Molecular cloning of a cDNA encoding a novel fatty acid-binding protein from rat skin. Biochem. Biophys. Res. Commun. 200, 253-259
16. Madsen, P., Rasmussen, H.H., Leffers, H., Honoré, B. and Celis, J.E. (1992) Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J. Invest. Dermatol. 99, 299-305
17. Siegenthaler, G., Hotz, R., Chatellard-Gruaz, D., Jaconi, S. and Saurat, J.H. (1993) Characterization and expression of a novel human fatty acid-binding protein: the epidermal type (E-FABP). Biochem. Biophys. Res. Commun. 190, 482-487
18. Krieg, P., Feil, S., Fürstenberger, G. and Bowden, G.T. (1993) Tumor-specific overexpression of a novel keratinocyte lipid-binding protein: identification and characterization of a cloned sequence activated during multistage carcinogenesis in mouse skin. J. Biol. Chem. 268, 17362-17369
19. De León, M., Welcher, A.A., Nahin, R.H., Liu, Y., Ruda, M.A., Shooter, E.M. and Molina, C.A. (1996) Fatty acid binding protein is induced in neurons of the dorsal root ganglia after peripheral nerve injury. J. Neurosci. Res. 44, 283-292
20. Wen, Y., Li, G.W., Chen, P., Wong, E. and Bekhor, I. (1995) Lens epithelial cell mRNA, II. Expression of a mRNA encoding a lipid-binding protein in rat lens epithelial cells. Gene 158, 269-274
21. Jaworski, C. and Wistow, G. (1996) LP2, a differentiation-associated lipid-binding protein expressed in bovine lens. Biochem. J. 320, 49-54
22. Masouyé, I., Hagens, G., Van Kuppevelt, T.H., Madsen, P., Saurat, J.H., Veerkamp, J.H., Pepper, M.S. and Siegenthaler, G. (1997) Endothelial cells of the human microvasculature express epidermal fatty acid-binding protein. Circ. Res. 81, 297-303
23. Smathers, R.L. and Petersen, D.R. (2011) The human fatty acid-binding protein family: evolutionary divergences and functions. Hum. Genomics 5, 170-191
24. Storch, J. and Thumser, A.E. (2010) Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 285, 32679-32683
25. Deaton, A.M. and Bird, A. (2011) CpG islands and the regulation of transcription. Genes Dev. 25, 1010-1022
26. Blattler, A. and Farnham, P.J. (2013) Cross-talk between site-specific transcription factors and DNA methylation states. J. Biol. Chem. 288, 34287-34294
27. Jones, P.A. (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484-492
28. Smith, Z.D. and Meissner, A. (2013) DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14, 204-220
29. Moss, T.J. and Wallrath, L.L. (2007) Connections between epigenetic gene silencing and human disease. Mutat. Res. 618, 163-174
30. Daniel, F.I., Cherubini, K., Yurgel, L.S., de Figueiredo, M.A. and Salum, F.G. (2011) The role of epigenetic transcription repression and DNA methyltransferases in cancer. Cancer 117, 677-687
31. Watanabe, R., Fujii, H., Yamamoto, A., Hashimoto, T., Kameda, K., Ito, M. and Ono, T. (1997) Immunohistochemical distribution of cutaneous fatty acid-binding protein in human skin. J. Dermatol. Sci. 16, 17-22
32. Klug, M. and Rehli, M. (2006) Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics 1, 127-130
33. Asakawa, S., Tsunematsu, K., Takayanagi, A., Sasaki, T., Shimizu, A., Shintani, A., Kawasaki, K., Mungall, A.J., Beck, S., Minoshima, S. and Shimizu, N. (2001) The genomic structure and promoter region of the human parkin gene. Biochem. Biophys. Res. Commun. 286, 863-868
34. Frommer, M., McDonald, L.E., Millar, D.S., Collis, C.M., Watt, F., Grigg, G.W., Molloy, P.L. and Paul, C.L. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. U.S.A. 89, 1827-1831
35. Kumaki, Y., Oda, M. and Okano, M. (2008) QUMA: quantification tool for methylation analysis. Nucleic Acids Res. 36, W170-W175
36. Oakes, C.C., La Salle, S., Robaire, B. and Trasler, J.M. (2006) Evaluation of a quantitative DNA methylation analysis technique using methylation-sensitive/dependent restriction enzymes and real-time PCR. Epigenetics 1, 146-152
37. Takai, D. and Jones, P.A. (2003) The CpG island searcher: a new WWW resource. In Silico Biol. 3, 235-240
38. Marinescu, V.D., Kohane, I.S. and Riva, A. (2005) MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 6, 79
39. Tomlins, S.A., Mehra, R., Rhodes, D.R., Cao, X., Wang, L., Dhanasekaran, S.M., Kalyana-Sundaram, S., Wei, J.T., Rubin, M.A., Pienta, K.J. et al. (2007) Integrative molecular concept modeling of prostate cancer progression. Nat. Genet. 39, 41-51
40. Grasso, C.S., Wu, Y.M., Robinson, D.R., Cao, X., Dhanasekaran, S.M., Khan, A.P., Quist, M.J., Jing, X., Lonigro, R.J., Brenner, J.C. et al. (2012) The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239-243
41. Aalinkeel, R., Nair, M.P., Sufrin, G., Mahajan, S.D., Chadha, K.C., Chawda, R.P. and Schwartz, S.A. (2004) Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res. 64, 5311-5321
42. Nemeth, J.A., Harb, J.F., Barroso, U., He, Z., Grignon, D.J. and Cher, M.L. (1999) Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res. 59, 1987-1993
43. Kovar, J.L., Johnson, M.A., Volcheck, W.M., Chen, J. and Simpson, M.A. (2006) Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am. J. Pathol. 169, 1415-1426
44. Kohli, R.M. and Zhang, Y. (2013) TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502, 472-479
45. Liang, G., Chan, M.F., Tomigahara, Y., Tsai, Y.C., Gonzales, F.A., Li, E., Laird, P.W. and Jones, P.A. (2002) Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol. 22, 480-491
46. Chen, T., Ueda, Y., Dodge, J.E., Wang, Z. and Li, E. (2003) Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23, 5594-5605
47. Fernandez, A.F., Huidobro, C. and Fraga, M.F. (2012) De novoDNA methyltransferases: oncogenes, tumor suppressors, or both? Trends Genet. 28, 474-479
48. Klose, R.J., Sarraf, S.A., Schmiedeberg, L., McDermott, S.M., Stancheva, I. and Bird, A.P. (2005) DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell 19, 667-678
49. Cameron, E.E., Bachman, K.E., Myöhänen, S., Herman, J.G. and Baylin, S.B. (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21, 103-107
50. Guo, M.M., Hu, L.H., Wang, Y.Q., Chen, P., Huang, J.G., Lu, N., He, J.H. and Liao, C.G. (2013) miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1. Med. Oncol. 30, 542
51. Xu, D., Takeshita, F., Hino, Y., Fukunaga, S., Kudo, Y., Tamaki, A., Matsunaga, J., Takahashi, R.U., Takata, T., Shimamoto, A. et al. (2011) miR-22 represses cancer progression by inducing cellular senescence. J. Cell Biol. 193, 409-424
52. Bao, Z., Malki, M.I., Forootan, S.S., Adamson, J., Forootan, F.S., Chen, D., Foster, C.S., Rudland, P.S. and Ke, Y. (2013) A novel cutaneous fatty acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells. Genes Cancer 4, 297-314
53. Powell, C.A., Nasser, M.W., Zhao, H., Wochna, J.C., Zhang, X., Shapiro, C., Shilo, K. and Ganju, R.K. (2015) Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability. Oncotarget 6, 6373-6385
54. Black, A.R., Black, J.D. and Azizkhan-Clifford, J. (2001) Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 188, 143-160
55. Safe, S. and Abdelrahim, M. (2005) Sp transcription factor family and its role in cancer. Eur. J. Cancer 41, 2438-2448
56. Beishline, K. and Azizkhan-Clifford, J. (2015) Sp1 and the 'hallmarks of cancer'. FEBS J. 282, 224-258
57. Hanahan, D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell 100, 57-70
58. Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
59. Brandeis, M., Frank, D., Keshet, I., Siegfried, Z., Mendelsohn, M., Nemes, A., Temper, V., Razin, A. and Cedar, H. (1994) Sp1 elements protect a CpG island from de novo methylation. Nature 371, 435-438
60. Dang, C.V., O'Donnell, K.A., Zeller, K.I., Nguyen, T., Osthus, R.C. and Li, F. (2006) The c-Myc target gene network. Semin. Cancer Biol. 16, 253-264
61. Knoepfler, P.S. (2008) Why myc? An unexpected ingredient in the stem cell cocktail. Cell Stem Cell 2, 18-21
62. Coller, H.A., Grandori, C., Tamayo, P., Colbert, T., Lander, E.S., Eisenman, R.N. and Golub, T.R. (2000) Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. U.S.A. 97, 3260-3265
63. Gurel, B., Iwata, T., Koh, C.M., Jenkins, R.B., Lan, F., Van Dang, C., Hicks, J.L., Morgan, J., Cornish, T.C., Sutcliffe, S. et al. (2008) Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod. Pathol. 21, 1156-1167
64. Massoner, P., Thomm, T., Mack, B., Untergasser, G., Martowicz, A., Bobowski, K., Klocker, H., Gires, O. and Puhr, M. (2014) EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205. Br. J. Cancer 111, 955-964
65. Münz, M., Kieu, C., Mack, B., Schmitt, B., Zeidler, R. and Gires, O. (2004) The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23, 5748-5758
66. Münz, M., Zeidler, R. and Gires, O. (2005) The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett. 225, 151-157
67. Currie, E., Schulze, A., Zechner, R., Walther, T.C. and Farese, R.V. (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18, 153-161
68. Liu, Y. (2006) Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer Prostatic Dis. 9, 230-234
69. Wu, X., Daniels, G., Lee, P. and Monaco, M.E. (2014) Lipid metabolism in prostate cancer. Am. J. Clin. Exp. Urol. 2, 111-120
70. Zadra, G., Photopoulos, C. and Loda, M. (2013) The fat side of prostate cancer. Biochim. Biophys. Acta 1831, 1518-1532
71. Dang, C.V., Le, A. and Gao, P. (2009) MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 15, 6479-6483
72. Dang, C.V. (2012) MYC on the path to cancer. Cell 149, 22-35